We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+19.36%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.81B
AUM Growth
+$561M
Cap. Flow
+$409M
Cap. Flow %
22.52%
Top 10 Hldgs %
16.32%
Holding
823
New
371
Increased
67
Reduced
65
Closed
283

Top Buys

Rank Stock Value
1
TPR icon
Tapestry
TPR
+$20.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$13.2M
3
SIX
Six Flags Entertainment Corp.
SIX
+$9.3M
4
KSA icon
iShares MSCI Saudi Arabia ETF
KSA
+$7.94M
5
CNC icon
Centene
CNC
+$7.13M

Top Sells

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$29.9M
2
EXAS
Exact Sciences
EXAS
+$12.2M
3
FIVE icon
Five Below
FIVE
+$6.65M
4
KSS icon
Kohl's
KSS
+$6.63M
5
BKS
Barnes & Noble
BKS
+$5.6M

Sector Composition

Rank Sector Weight
1 Healthcare 3.91%
2 Consumer Discretionary 2.56%
3 Technology 1.71%
4 Energy 1.64%
5 Industrials 1.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOVA
526
CALL
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$104K 0.01%
+11,700
New +$95K
AQMS icon
527
Aqua Metals
AQMS
$8.99M
$85K ﹤0.01%
140
– –
CORT icon
528
Corcept Therapeutics
CORT
$12.4B
$81K ﹤0.01%
+6,900
New +$85.7K
MHK icon
529
CALL
Mohawk Industries
MHK
$7.5B
$75K ﹤0.01%
600
– –
STZ icon
530
Constellation Brands
STZ
$22.2B
$71K ﹤0.01%
+400
New +$67.4K
WFT
531
DELISTED
Weatherford International plc
WFT
$70K ﹤0.01%
+100,000
New +$69.2K
APYX icon
532
Apyx Medical
APYX
$173M
$63K ﹤0.01%
+10,000
New +$77.4K
TRN icon
533
PUT
Trinity Industries
TRN
$2.48B
$56K ﹤0.01%
2,600
– –
HSTO
534
DELISTED
Histogen Inc. Common Stock
HSTO
$54K ﹤0.01%
250
-125
-33% -$50.4K
DVAX
535
DELISTED
Dynavax Technologies
DVAX
$53K ﹤0.01%
+7,200
New +$70.4K
AKBA icon
536
Akebia Therapeutics
AKBA
$354M
$49K ﹤0.01%
+6,000
New +$41.2K
TUSK icon
537
Mammoth Energy Services
TUSK
$128M
$48K ﹤0.01%
+2,900
New +$61.9K
GPRO icon
538
GoPro
GPRO
$130M
$33K ﹤0.01%
5,000
-75,000
-94% -$420K
MRTX
539
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$7K ﹤0.01%
+100
New +$6.8K
IMGN
540
DELISTED
Immunogen Inc
IMGN
$3K ﹤0.01%
1,200
-169,550
-99% -$734K
ABUS icon
541
CALL
Arbutus Biopharma
ABUS
$857M
– –
-30,000
Closed -$115K
ABUS icon
542
Arbutus Biopharma
ABUS
$857M
– –
-5,000
Closed -$20K
ABUS icon
543
PUT
Arbutus Biopharma
ABUS
$857M
– –
-30,000
Closed -$115K
ACM icon
544
CALL
Aecom
ACM
$9.3B
– –
-24,700
Closed -$655K
ADAP
545
CALL
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-135,000
Closed -$776K
ADAP
546
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-50,960
Closed -$293K
AKAM icon
547
Akamai
AKAM
$16.7B
– –
-42,000
Closed -$2.56M
ALLT icon
548
Allot
ALLT
$372M
– –
-650,654
Closed -$3.95M
ALLY icon
549
Ally Financial
ALLY
$13.2B
– –
-71,616
Closed -$1.62M
ALLY icon
550
PUT
Ally Financial
ALLY
$13.2B
– –
-79,600
Closed -$1.8M
20 21
22
23 24

Similar funds

ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $16.7B AUM 23.27% 1-Year Est. Return

Caption Management's Q1 2019 Portfolio in Review

As of Q1 2019, Caption Management held 823 positions worth $1.81B, up 45% from $1.25B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management deployed $409M of net new capital in Q1 2019, opening 371 new positions and adding to 67 existing holdings. Its largest new stake was Tapestry: 580,000 shares worth $18.8M.

By sector, the portfolio is most concentrated in Healthcare at 3.9% of assets, down from 4.5% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Somnigroup International, an estimated $4.33M trimmed.

  • Caption Management's largest Q1 2019 buy was Tapestry: 580,000 shares worth $18.8M.
  • Caption Management added most to Bristol-Myers Squibb in Q1 2019, an estimated $13.2M increase.
  • Caption Management's biggest Q1 2019 reduction was Somnigroup International, cutting an estimated $4.33M.
  • Caption Management fully exited Caesars Entertainment in Q1 2019, selling an estimated $29.9M.
  • Caption Management's ten largest holdings make up 16% of its $1.81B portfolio in Q1 2019.
  • Caption Management opened 371 new positions and closed 283 in Q1 2019.
  • Caption Management's portfolio value rose 45% quarter-over-quarter to $1.81B.

Based on Caption Management's 13F filing for Q1 2019, filed 14 May 2019.